Exact Mass: 401.24134000000004

Exact Mass Matches: 401.24134000000004

Found 131 metabolites which its exact mass value is equals to given mass value 401.24134000000004, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Calpain inhibitor II

N-Acetylleucyl-leucyl-methioninal

C19H35N3O4S (401.2348150000001)


   

6'-Hydroxybuspirone

6-hydroxy-8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione

C21H31N5O3 (401.2426776)


6-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)

   

Buspirone N-oxide

8-{4-[1-oxo-4-(pyrimidin-2-yl)-1λ⁵-piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione

C21H31N5O3 (401.2426776)


Buspirone N-oxide is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)

   

3'-Hydroxybuspirone

2-hydroxy-8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione

C21H31N5O3 (401.2426776)


3-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)

   

5-Hydroxybuspirone

8-{4-[4-(5-hydroxypyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione

C21H31N5O3 (401.2426776)


5-Hydroxybuspirone is a metabolite of buspirone. Buspirone is an anxiolytic psychoactive drug of the azapirone chemical class, and is primarily used to treat generalized anxiety disorder (GAD) Bristol-Myers Squibb (BMS) gained FDA approval of buspirone in 1986 for treatment of GAD. The patent on Buspar by Bristol-Myers Squibb expired in 2001, and buspirone is available as a generic. (Wikipedia)

   

5-Methylurapidil

6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3,5-trimethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

C21H31N5O3 (401.2426776)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

Isoquinoline, 1,2,3,4-tetrahydro-2-(4-amino-6-((4-phenyl-1-piperazinyl)methyl)-s-triazin-2-yl)-

Isoquinoline, 1,2,3,4-tetrahydro-2-(4-amino-6-((4-phenyl-1-piperazinyl)methyl)-s-triazin-2-yl)-

C23H27N7 (401.23278220000003)


   

[2-Amino-2-(hydroxymethyl)-5-(4-octylphenyl)pentyl] dihydrogen phosphate

2-Amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol monodihydrogen phosphate ester

C20H36NO5P (401.23309760000006)


   

N-Allm

2-acetamido-4-methyl-N-(3-methyl-1-{[4-(methylsulfanyl)-1-oxobutan-2-yl]carbamoyl}butyl)pentanamide

C19H35N3O4S (401.2348150000001)


   

glutaminylvalylarginine

glutaminylvalylarginine

C16H31N7O5 (401.2386556)


   
   
   
   
   

valylglutaminylarginine

valylglutaminylarginine

C16H31N7O5 (401.2386556)


   
   

asparagylisoleucylarginine

asparagylisoleucylarginine

C16H31N7O5 (401.2386556)


   
   
   

Ala Gly Arg Val

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Ala Gly Val Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Ala Arg Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]acetamido}-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Ala Arg Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Ala Val Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Ala Val Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

DIDESMETHYL MIFEPRISTONE

N-Didesmethylmifepristone (RU 42848)

C27H31NO2 (401.2354666)


   

Gly Ala Arg Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Gly Ala Val Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

5-Hydroxybuspirone

5-Hydroxy Buspirone

C21H31N5O3 (401.2426776)


   

Gly Gly Ile Arg

(2S)-2-[(2S,3S)-2-[2-(2-aminoacetamido)acetamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Gly Leu Arg

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Gly Arg Ile

(2S,3S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Gly Arg Leu

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Ile Gly Arg

(2S)-2-{2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Ile Arg Gly

2-[(2S)-2-[(2S,3S)-2-(2-aminoacetamido)-3-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Gly Leu Gly Arg

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Leu Arg Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-methylpentanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Ala Val

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]propanamido]-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Gly Ile

(2S,3S)-2-{2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]acetamido}-3-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Gly Leu

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]acetamido}-4-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Ile Gly

2-[(2S,3S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylpentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Leu Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-4-methylpentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Gly Arg Val Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-5-carbamimidamidopentanamido]-3-methylbutanamido]propanoic acid

C16H31N7O5 (401.2386556)


   

Gly Val Ala Arg

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]propanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Gly Val Arg Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-5-carbamimidamidopentanamido]propanoic acid

C16H31N7O5 (401.2386556)


   

Ile Gly Gly Arg

(2S)-2-(2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}acetamido)-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Ile Gly Arg Gly

2-[(2S)-2-{2-[(2S,3S)-2-amino-3-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   
   

Ile Arg Gly Gly

2-{2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}acetic acid

C16H31N7O5 (401.2386556)


   
   
   

Leu Gly Gly Arg

(2S)-2-(2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}acetamido)-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Leu Gly Arg Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Leu Arg Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]acetamido}acetic acid

C16H31N7O5 (401.2386556)


   
   
   
   
   
   
   
   
   

Arg Ala Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]acetamido}-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Arg Ala Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]propanamido]-3-methylbutanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Ala Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}propanamido]-3-methylbutanoic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Gly Ile

(2S,3S)-2-(2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}acetamido)-3-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Gly Leu

(2S)-2-(2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}acetamido)-4-methylpentanoic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Ile Gly

2-[(2S,3S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylpentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Leu Gly

2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-4-methylpentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Arg Gly Val Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-5-carbamimidamidopentanamido]acetamido}-3-methylbutanamido]propanoic acid

C16H31N7O5 (401.2386556)


   

Arg Ile Gly Gly

2-{2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]acetamido}acetic acid

C16H31N7O5 (401.2386556)


   

Arg Leu Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]acetamido}acetic acid

C16H31N7O5 (401.2386556)


   

Arg Val Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]propanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Arg Val Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]acetamido}propanoic acid

C16H31N7O5 (401.2386556)


   
   
   
   

Val Ala Gly Arg

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]acetamido}-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Val Ala Arg Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]propanamido]-5-carbamimidamidopentanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Val Gly Ala Arg

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}propanamido]-5-carbamimidamidopentanoic acid

C16H31N7O5 (401.2386556)


   

Val Gly Arg Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-5-carbamimidamidopentanamido]propanoic acid

C16H31N7O5 (401.2386556)


   

Val Arg Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]propanamido]acetic acid

C16H31N7O5 (401.2386556)


   

Val Arg Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]acetamido}propanoic acid

C16H31N7O5 (401.2386556)


   
   

ALLM (Calpain Inhibitor)

ALLM (Calpain Inhibitor)

C19H35N3O4S (401.2348150000001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins

   

4-(3,4-dihydro-2H-quinolin-1-yl)-6-[(4-phenyl-1-piperazinyl)methyl]-1,3,5-triazin-2-amine

4-(3,4-dihydro-2H-quinolin-1-yl)-6-[(4-phenyl-1-piperazinyl)methyl]-1,3,5-triazin-2-amine

C23H27N7 (401.23278220000003)


   
   

Dehydrocholate

Dehydrocholate

C24H33O5- (401.23278680000004)


D005765 - Gastrointestinal Agents > D002756 - Cholagogues and Choleretics D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

ALLM

N-Acetylleucyl-leucyl-methioninal

C19H35N3O4S (401.2348150000001)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors

   
   

[1-(3-Phenoxypropyl)-4-piperidinyl]-diphenylmethanol

[1-(3-Phenoxypropyl)-4-piperidinyl]-diphenylmethanol

C27H31NO2 (401.2354666)


   

1-ethyl-4-hydroxy-2-oxo-N-(1-oxodecyl)-3-quinolinecarbohydrazide

1-ethyl-4-hydroxy-2-oxo-N-(1-oxodecyl)-3-quinolinecarbohydrazide

C22H31N3O4 (401.23144460000003)


   
   
   
   

5,6-dimethyl-2-[1-[[1-(phenylmethyl)-5-tetrazolyl]methyl]-4-piperidinyl]-1H-benzimidazole

5,6-dimethyl-2-[1-[[1-(phenylmethyl)-5-tetrazolyl]methyl]-4-piperidinyl]-1H-benzimidazole

C23H27N7 (401.23278220000003)


   

1-[2-[[(2,3-dihydro-1H-inden-5-ylamino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

1-[2-[[(2,3-dihydro-1H-inden-5-ylamino)-oxomethyl]amino]-2-methyl-1-oxopropyl]-4-piperidinecarboxylic acid ethyl ester

C22H31N3O4 (401.23144460000003)


   
   

Crambescidin 401

Crambescidin 401

C22H31N3O4 (401.23144460000003)


An organic heteropentacyclic guanidine alkaloid isolated from the marine sponge Crambe crambe.

   

(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3R)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

2-[(2S,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2S,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2S,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2S,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2S,3S)-8-[2-(1-hydroxycyclopentyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C22H31N3O4 (401.23144460000003)


   

2-[(2S,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2S,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2R,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2R,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2R,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2R,3S,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2R,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2R,3R,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2S,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2S,3S,6S)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   

2-[(2R,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

2-[(2R,3R,6R)-3-[[(cyclohexylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-(phenylmethyl)acetamide

C22H31N3O4 (401.23144460000003)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Ro 64-6198

Ro 64-6198

C26H31N3O (401.2466996)


Ro 64-6198 is a potent, selective, nonpeptide, high-affinity, high cellular permeability and brain penetration N/OFQ receptor (NOP) agonist with an EC50 value of 25.6 nM. Ro 64-6198 is at least 100 times more selective for the NOP receptor over the classic opioid receptors. Ro 64-6198 can be used for stress and anxiety, addiction, neuropathic pain, cough, and anorexia[1][2].